Business Daily.
.
A+ R A-

Cynvenio to Present New Clinical Data on Concordance Characteristics of Circulating Cell-Free Nucleic Acids in Metastatic Cancer Mutations at Molecular Diagnostics Europe

E-mail Print
LOS ANGELES--(BUSINESS WIRE)--Cynvenio will present findings that establish that both CTC DNA and cfDNA can be used as complementary data types for the analysis of tumor-associated mutations at Molecular Diagnostics Europe.

imageimage

Read more

Business Daily Media